Objective: Admission for acute coronary syndrome after successful percutaneous coronary intervention is a delicate situation for the patient and doctor. Predictors of these cases are poorly described.
Methods: We retrospectively analysed the files of post-percutaneous coronary intervention patients admitted to the Department of Cardiology of the Institute for Cardiovascular Disease and Heart Transplant in Tirgu Mures between January 2012 and December 2015. Analyses using the t-test, chi-square test, and Fisher test were performed to compare demographics, clinical and angiographic characteristics of patients with acute coronary syndrome, patients with stable angina, and those without symptoms.
Results: One hundred eighty post-percutaneous coronary intervention patients were readmitted; 46 patients (25.55%) were readmitted for acute coronary syndrome. Histories of arterial hypertension and renal dysfunction at hospital admission were associated with acute coronary syndrome. Bare metal stent in-stent restenosis and localisation of bare metal stent in-stent restenosis of the left descendent coronary artery were angiographic predictors of acute coronary syndrome.
Conclusion: Several clinical and angiographic factors identify patients at high risk for acute coronary syndrome after successful percutaneous coronary intervention. Recognition and treatment of these factors may prevent readmission for such a dangerous condition and may improve outcomes.
1. Dorobantu M, Tautu OF, Fruntelata A, et al – Hypertension and acute coronary syndromes in Romania: data from the ISACS-TC registry. Eur Heart J Suppl. 2014;16:A20-A27.
2. Kim JH, Chae SC, Oh DJ, et al – Multicenter cohort study of acute myocardial infarction in Korea—interim analysis of the Korea acute myocardial infarction registry-national institutes of health registry. Circ J. 2016;80:1427-1436.
3. Fresco C, Avanzini F, Bosi S, et al – Prognostic value of a history of hypertension in 11,483 patients with acute myocardial infarction treated with thrombolysis. GISSI-2 Investigators. Gruppo Italiano per lo Studio della, Sopravvivena nell’Infarto Miocardico. J Hypertens. 1996;14:743–750.
4. Hadadi L, Somkereki C, Dobreanu D. Renal dysfunction at hospital admission, high complexity of coronary artery disease and short term prognosis in acute ST-segment elevation myocardial infarction. Rev Romana Med Lab. 2012;20:363-369.
5. Washam JB, Herzog CA, Beitelshees AL, et al – Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: a scientific statement from the American Heart Association. Circulation. 2015;131:1123-1149.
6. Baber U, Stone GW, Weisz G, et al – Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5(3 Suppl):S53-S61.
7. Bønaa K, Mannsverk J, Wiseth R, et al – Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med. 2016;375:1242-1252.
8. Wasilewski J, Niedziela J, Osadnik T, et al – Predominant location of coronary artery atherosclerosis in the left anterior descending artery. The impact of septal perforators and the myocardial bridging effect. Kardiochir Torakochirurgia Pol. 2015;12:379–385.
9. Zou Y, Huang X, Feng L, et al – Localization of in-stent neoatherosclerosis in relation to curvatures and bifurcations after stenting. J Thorac Dis. 2016;8:3530-536.